Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Liver Int. 2015 Mar;35(3):713-23. doi: 10.1111/liv.12529. Epub 2014 Apr 4.
BACKGROUND & AIMS: Chronic liver disease is a common comorbidity in surgery. To assess post-operative morbidity and mortality in relation to progression of chronic liver disease and to identify the risk factors.
Six hundred and nine consecutive patients with chronic liver disease who underwent surgery were classified into two groups: non-cirrhotic (n = 363) and cirrhotic (n = 246). Randomly selected patients without underlying liver disease who underwent surgery were used as control group (n = 148).
The occurrence of major post-operative complications was higher in the non-cirrhotic group than in the control group (11.8% vs. 6.1%, P = 0.051); age, type of surgery and serum albumin level were independent predictors for post-operative morbidity. The frequency of significant post-operative liver damage (14.9% vs. 12.2%, P = 0.920) and mortality (0.6% vs. 0.7%, P = 0.871) did not differ between the two groups. The cirrhotic group had markedly higher incidences of post-operative mortality (10.2%), major complications (32.5%) and significant liver damage (43.1%) than the control and non-cirrhotic groups (all P < 0.001). Type of surgery, Child-Pugh score and model for end-stage liver disease score were independently associated with post-operative morbidity and mortality in patients with cirrhosis. Specific data regarding post-operative morbidity and mortality were presented according to progression of liver disease and type of surgery.
Non-cirrhotic chronic liver diseases were associated with higher risk of post-operative morbidity, particularly in cases of major surgery, older age and hypoalbuminaemia. Cirrhosis further increased the risk, even death, depending on degree of hepatic decompensation and type of surgery.
慢性肝脏疾病是外科手术中的常见合并症。本研究旨在评估慢性肝脏疾病的进展与术后发病率和死亡率的关系,并确定相关的危险因素。
将 609 例连续接受手术治疗的慢性肝脏疾病患者分为非肝硬化组(n = 363)和肝硬化组(n = 246)。随机选择无潜在肝脏疾病的患者作为对照组(n = 148)。
非肝硬化组的主要术后并发症发生率高于对照组(11.8% vs. 6.1%,P = 0.051);年龄、手术类型和血清白蛋白水平是术后发病率的独立预测因素。两组之间术后肝损伤的发生率(14.9% vs. 12.2%,P = 0.920)和死亡率(0.6% vs. 0.7%,P = 0.871)差异无统计学意义。肝硬化组的术后死亡率(10.2%)、主要并发症发生率(32.5%)和显著肝损伤发生率(43.1%)明显高于对照组和非肝硬化组(均 P < 0.001)。手术类型、Child-Pugh 评分和终末期肝病模型评分是与肝硬化患者术后发病率和死亡率相关的独立因素。根据疾病进展和手术类型,分别提供了术后发病率和死亡率的具体数据。
非肝硬化性慢性肝脏疾病与术后发病率升高相关,尤其是在大手术、年龄较大和低白蛋白血症的情况下。肝硬化进一步增加了风险,甚至死亡,具体取决于肝功能失代偿的程度和手术类型。